A volunteer in Chennai claimed to have suffered severe symptoms after injecting the vaccine. (Figurative) New Delhi: An investigation initiated by the Comptroller General of Drugs of India (DCGI) into a suspected “serious adverse event” allegedly suffered by a participant in the Oxford COVID-19 vaccine trial in Chennai found that …
Read More »
India will be our priority in distributing the coronavirus vaccine, Adar Poonawalla, executive director of the Serum Institute of India, said on Saturday. The world’s largest vaccine manufacturer by volume has teamed up with British-Swedish company AstraZeneca to produce the COVID-19 vaccine for the University of Oxford for low- and …
Read More »
Written by Abhishek De, edited by Explained Desk | New Delhi | Updated: November 20, 2020 4:07:53 pm An actor dressed as a coronavirus reacts after injecting a fantasy vaccine during a street performance in Plaza San Martín (AP) Encouraging results in Covid-19 vaccine trials by pioneers in November have …
Read More »
Written by Kaunain Sheriff M | New Delhi | Updated: November 20, 2020 9:52:14 am “Further evaluation of the efficacy of this vaccine is warranted in all age groups and individuals with comorbidities,” the researchers said. The Oxford-AstraZeneca Covid-19 candidate vaccine has triggered a robust immune response in older adults …
Read More »
COVID-19 vaccines are likely to be a reality soon. Several candidates in the global coronavirus vaccine race have come a little closer to regulatory approval in recent weeks. “The coronavirus vaccine will be available in the coming months and it is estimated that between 400 and 500 million doses will …
Read More »
By: Desk Explained | New Delhi | Updated: November 15, 2020 11:44:36 pm Collecting swabs for rapid Covid-19 testing at a municipal dispensary in Deonar in Mumbai (Express Photo by Amit Chakravarty) Vaccine against the coronavirus (Covid-19): After Pfizer, another US drugmaker, Moderna Inc, is likely to release the first …
Read More »
The Serum Institute of India (SII) has prepared 4 million doses of the new coronavirus vaccine. “IBS has already manufactured 40 million doses of the vaccine, under DCGI’s manufacturing and storage at risk license,” the company said in a statement. The SII, with the help of the Indian Council of …
Read More »
The Serum Institute of India (SII) has joined five candidate vaccines to fight the deadly novel coronavirus, Adar Poonawalla said. Earlier this year, the Pune-based drugmaker signed an agreement with British-Swedish firm AstraZeneca to manufacture its experimental vaccine developed by the University of Oxford. The Oxford COVID-19 vaccine is currently …
Read More »
A safe and effective vaccine against the new coronavirus may be available in India by January 2021, says Adar Poonawalla, executive director (CEO) of the Serum Institute of India. The Pune-based drugmaker teamed up with major British-Swedish drugmaker AstraZeneca to produce the coronavirus vaccine for low- and middle-income countries, developed …
Read More »
The search for a safe and effective vaccine against the new coronavirus is underway. Frontline workers will be the first to get vaccinated in India when a vaccine becomes available, according to a senior official. “Reducing mortality and protecting frontline workers must be the first priority,” said Dr. Vinod Paul, …
Read More »